And indeed, over 70% of recipients with at least one classical HLA mismatch developed aGvHD in stages I–IV and 55% in stages II–IV (although these differences did not reach statistical significance, p = 0.243 and p = 0.218, respectively).
← all excerpts
The impact of NKG2A and NKG2D receptors and HLA-E and MICA ligands polymorphisms on post-transplant complications after paediatric allogeneic HSCT: a single-centre experience.
1
0.2430
0.2430